PHILADELPHIA investigational site — Philadelphia, Pennsylvania

PHILADELPHIA investigational site is a clinical research site located in Philadelphia, Pennsylvania, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

PHILADELPHIA investigational site has participated in 1 clinical trials.

Therapeutic areas: Kidney Transplant.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PHILADELPHIA investigational site?

PHILADELPHIA investigational site has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PHILADELPHIA investigational site conducted?

PHILADELPHIA investigational site has 1 clinical trials on record. Their work covers Kidney Transplant.

Is PHILADELPHIA investigational site accredited by Crixeo Health?

PHILADELPHIA investigational site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PHILADELPHIA investigational site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.